The National Institutes of Health (NIH) and the Office of Biotechnology Activities require that universities maintain the highest level of scientific integrity and community safety in the review of research involving genetic engineering, the splicing together of DNA from different organisms. Strict rules have been established regarding types of experimentation allowable and under what circumstances different classes of experiments can be conducted. The NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules (NIH Guidelines) detail safety practices and containment procedures for basic and clinical research involving recombinant or synthetic nucleic acid molecules, including the creation and use of organisms and viruses containing recombinant or synthetic nucleic acid molecules.
Prior to Protocol Submission
Prior to submitting a protocol to the IBC for review please contact J. Kelly Donovan, Biosafety Officer by phone at 607-777-6834 or by email at firstname.lastname@example.org to let him know the type of research you are planning to do in your lab.
If you have a protocol that requires review by the IBC please fill out the form here. (Save to computer to be able to fill and sign.) Submit the filled out form and any attachments to email@example.com for initial review. If there are no concerns found on initial review, the Research Compliance office will submit the protocol to the IBC. You will be notified that the protocol was submitted to the IBC. Typically, notification of required modifications or approval will be submitted to the PI within 14 calendar days of the IBC receiving the protocol. If the protocol is deemed exempt by the IBC, you may be notified sooner.
Protocols are approved for 3 years. Annual reports are required during that 3-year period. You can find the IBC Annual Review form here. (Save to computer to be able to fill and sign.) Please fill it out and submit the Annual Review form 30 days prior to the annual anniversary of approval date to firstname.lastname@example.org. If you should need to continue your protocol past 3 years, a new protocol submission is required.
If you should make any modifications (including but not limited to: key personnel changes, lab location changes, changes to the originally planned research) at any time after your initial approval, you are required to notify the IBC of these modifications. You can find the IBC Modifications form here. (Save to computer to be able to fill and sign.) Please fill it out and submit to email@example.com
Online Biosafety Training Requirement
Beginning July 1, 2017 all undergraduate students, graduate students, and post-doctoral researchers participating on any IBC approved protocol will be required to complete the online Initial Biosafety Training. Binghamton University utilizes Collaborative Institutional Training Initiative (CITI) to complete online training programs. This same program is in use by many research-intensive universities nationwide.
Procedures for Online CITI Training
Binghamton University faculty, staff and students Log into CITI via Single Sign On (SSO) and chose SUNY-University at Binghamton LINK TO CITI
If you are not already registered with CITI, you will need to register here:
When you complete registration or sign in you will need to register for the course.
Click on the Main Menu Tab and add a course:
Skip questions numbered 1 through 7
For question 8, select: Introduction to Biosafety
You will need to accept the acknowledgement for the course prior to beginning.
Should you need information about the IBC, contact: David Davies, committee chair, at firstname.lastname@example.org.
For all other questions or concerns please contact the Research Compliance Office by phone at 607-777-4664 or by email at email@example.com or Contact Nancy Lewis, Assistant Vice President of Research Compliance by phone at 607-777-3532 or by email at firstname.lastname@example.org
You can find the Select Agents, Pathogens and Toxins Notification of Possession form here.